Richard Mulligan Biogen Inc. (BIIB) insider trading activity

Richard Mulligan is Director of BIOGEN INC.. Currently has a direct ownership of 15,099 shares of BIIB, which is worth approximately $2.62 Million. The most recent transaction as insider was on Jun 15, 2022, when has been sold 1,370 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 15.1K

0% 3M change

0% 12M change

Total Value Held $2.62 Million

Richard Mulligan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Jun 15 2022	BUY Grant, award, or other acquisition	-	1,370 Added 8.32%	15,099 Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	775 Added 5.34%	13,729 Common Stock

Also insider at

SANA

Sana Biotechnology, Inc. Healthcare

BHC

Bausch Health Companies Inc. Healthcare

Director